Axis-Shield PoC Company Profile

14:50 EST 13th December 2018 | BioPortfolio

Axis-Shield PoC is member of the Axis-Shield group. Axis-Shield is an innovative healthcare company comprising Laboratory and Point of Care business backed by a strong R&D division. Axis-Shield PoC's philosophy
We aim to be a driving force in the Point of Care market as a supplier of in-vitro diagnostic products. We are dedicated to develop innovative test systems to the benefit of physicians and patients.
Market position
Axis-Shield PoC has more than 40 years experience in development, manufacturing, marketing and sales of in-vitro diagnostic products. Collaboration with scientific institutions and companies throughout the world has brought several unique products to the market: Thrombotest™, Lymphoprep™ as well as NycoCard™, a product portfolio for use in the Point of Care segment.
Axis-Shield PoC has a strong market position with more than 14.000 NycoCard™ Readers and 4.000 Thrombotrack™ instruments placed all over the world.


10 Commerce Way
United States of America


Phone: 1 508 285 4870
Fax: 1 508 285 4840

News Articles [270 Associated News Articles listed on BioPortfolio]

CORRECTION: Psoria-Shield, Inc. and Neo Phototherapy LLC Developing Next Generation LED Phototherapy Device

HOFFMAN ESTATES, IL, Nov. 27, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Wellness Center USA, Inc. (OTCQB: WCUI) and Psoria-Shield, Inc. (PSI) today announced the formation of a Joint Ven...

Athenex Announces Axis Therapeutics Enters into MOU with Hong Kong Polytechnic University

Athenex (NASDAQ:ATNX) has announced that Axis Therapeutics has entered into an MOU with the Kong Kong Polytechnic University to explore the establishment of a joint research center to advance the appl...

US FDA to make decision on Shield Therapeutics’ Feraccru drug by end of July

The US is a huge and potentially lucrative market that Shield is understandably keen to crack

Shield files Feraccru with the FDA

The UK’s Shield Therapeutics has successfully submitted an application to market iron deficiency therapy Feraccru in the US.

Blue Cross Blue Shield of Georgia (BCBSGa) to Change Brand Name to Anthem Blue Cross and Blue Shield

Blue Cross and Blue Shield of Georgia (BCBSGa), which includes Blue Cross and Blue Shield of Georgia, Inc. and Blue Cross Blue Shield Healthcare Plan of Georgia, Inc., is changing...

Norgine launches Shield’s Feraccru in the UK

Norgine has launched Feraccru across the UK to treat patients with iron deficiency anaemia, having picked up rights to sell the drug from Shield Therapeutics earlier this year.

Norgine to commercialize Shield’s iron deficiency therapy in Europe, Australia and New Zealand

Under the terms of the agreement, Shield will receive an immediate £11 million upfront payment, is eligible to receive up to €4.5m in short-term development milestones and up The post Norgine to c...

Daiki Axis Co., Ltd. (4245, First Section, Tokyo Stock Exchange) Issues Operating Performance ...

TOKYO, Nov. 20, 2018 /PRNewswire/ -- Daiki Axis (TOKYO: 4245) is pleased to announce its results for the nine months ended September 30, 2018. Summary Read more...

PubMed Articles [569 Associated PubMed Articles listed on BioPortfolio]

Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model.

Endovascular treatment of intracranial aneurysms with endoluminal flow diverters (single or multiple) has proven to be clinically safe and effective, but is associated with a risk of thromboembolic co...

Phylogenetic, ecological and biomechanical constraints on larval form: A comparative morphological analysis of barnacle nauplii.

Barnacle naupliar larvae are differentiated from other zooplankton by their unique pair of frontal lateral horns, frontal filaments, and a pear-shaped cephalic shield. Their morphology impose constrai...

Evolution: Directives from Sea Anemone Hox Genes.

A new study in a sea anemone shows that, as in bilaterian animals, an axis-patterning Hox code exists in cnidarians. Surprisingly, it acts along the directive axis, orthogonal to the oral-aboral axis.

Publisher Correction: The early history of wheat in China from C dating and Bayesian chronological modelling.

In the version of this Article originally published, the x and y axis labels in Fig. 1 were switched over; the correct labels are: 'Longitude (° N)' on the x axis, and 'Latitude (° E)' on the y axis...

Pipeline embolization device with Shield technology for intracranial aneurysms: An initial United States experience.

Thromboembolic complications remain a major reason for morbidity and mortality after flow diversion along with hemorrhagic complications not limited to the brain predicated on the prolonged need for d...

Clinical Trials [288 Associated Clinical Trials listed on BioPortfolio]

Influence of the Brownie Breast Shield on the Dynamics of Milk Removal

The purpose of this study is to investigate the efficacy of breast drainage of the healthy breast with the new Medela pump set breast shield (Brownie). The objective of the study is to ve...

I-ZIP Ocular Bandage Pivotal Study

To evaluate the safety and performance of the I-ZIP Ocular Bandage in subjects undergoing uneventful unilateral clear corneal phacoemulsification with foldable monofocal intraocular lens (...

Comparison of Peri-implant Tissues Using Socket Shield Technique Versus Xenograft

The aim of this study is to clinically and radiographically evaluate the dimensional changes of soft and hard peri-implant tissues around single immediate post-extraction implants in the e...

Impact of Breast Shield Designs on Dynamics of Breast Pumping

A prospective, randomized, 2-phase/crossover, single center premarket feasibility study. In phase I the comfort will be assessed, the occurence and types of adverse events will be recorded...

Socket Shield Technique Versus Conventional Immediate Implant Placement in Thin Buccofacial Bone

Buccal bone is prone to resorb after tooth extraction specially with immediate tooth implantation which could compromise the esthetics of the patient. socket shield technique retains the b...

Companies [170 Associated Companies listed on BioPortfolio]

Axis-Shield PoC

Axis-Shield PoC is member of the Axis-Shield group. Axis-Shield is an innovative healthcare company comprising Laboratory and Point of Care business backed by a strong R&D division. Axis-Shield PoC's ...

Axis-Shield plc

Axis-Shield ( is an international and innovative in vitro diagnostics company, headquartered in Dundee with R&D and manufacturing bases in Dundee and Oslo. The Group spe...

AXIS Capital Holdings Limited

AXIS Capital is a Bermuda-based global provider of specialty lines insurance and treaty reinsurance with total shareholders’ equity attributable to AXIS Capital at December 3...

Axis Communications, Inc.

As the market leader in network video, Axis is leading the way to a smarter, safer, more secure world – driving the shift from analog to digital video surveillance. Offering ...

Axis Technology, LLC

Founded in 2000, Axis Technology, LLC is a premier provider of data solutions for enterprises whose business success depends on protecting customer and proprietary information. Th...

More Information about "Axis-Shield PoC" on BioPortfolio

We have published hundreds of Axis-Shield PoC news stories on BioPortfolio along with dozens of Axis-Shield PoC Clinical Trials and PubMed Articles about Axis-Shield PoC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axis-Shield PoC Companies in our database. You can also find out about relevant Axis-Shield PoC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record